These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


639 related items for PubMed ID: 9459566

  • 1. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
    Mazzoni MR, Buffoni RS, Giusti L, Lucacchini A.
    J Recept Signal Transduct Res; 1995 Jan; 15(7-8):905-29. PubMed ID: 8673723
    [Abstract] [Full Text] [Related]

  • 3. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP, Curtis AR, Kendall DA, Hill SJ.
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [Abstract] [Full Text] [Related]

  • 4. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [Abstract] [Full Text] [Related]

  • 5. Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells.
    Mundell SJ, Kelly E.
    Biochem Pharmacol; 1998 Mar 01; 55(5):595-603. PubMed ID: 9515570
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
    Feoktistov I, Biaggioni I.
    Biochem Pharmacol; 1998 Mar 01; 55(5):627-33. PubMed ID: 9515573
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.
    Jacobson KA, Siddiqi SM, Olah ME, Ji XD, Melman N, Bellamkonda K, Meshulam Y, Stiles GL, Kim HO.
    J Med Chem; 1995 May 12; 38(10):1720-35. PubMed ID: 7752196
    [Abstract] [Full Text] [Related]

  • 9. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
    Prentice DJ, Hourani SM.
    Br J Pharmacol; 1996 Jul 12; 118(6):1509-17. PubMed ID: 8832079
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells.
    Suh BC, Kim TD, Lee JU, Seong JK, Kim KT.
    Br J Pharmacol; 2001 Sep 12; 134(1):132-42. PubMed ID: 11522605
    [Abstract] [Full Text] [Related]

  • 11. Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery.
    Prentice DJ, Payne SL, Hourani SM.
    Br J Pharmacol; 1997 Dec 12; 122(7):1509-15. PubMed ID: 9421303
    [Abstract] [Full Text] [Related]

  • 12. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
    Klotz KN, Camaioni E, Volpini R, Kachler S, Vittori S, Cristalli G.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug 12; 360(2):103-8. PubMed ID: 10494877
    [Abstract] [Full Text] [Related]

  • 13. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S.
    Br J Pharmacol; 1996 Apr 12; 117(7):1381-6. PubMed ID: 8730729
    [Abstract] [Full Text] [Related]

  • 14. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
    Zhou QY, Li C, Olah ME, Johnson RA, Stiles GL, Civelli O.
    Proc Natl Acad Sci U S A; 1992 Aug 15; 89(16):7432-6. PubMed ID: 1323836
    [Abstract] [Full Text] [Related]

  • 15. Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors.
    Hill RJ, Oleynek JJ, Hoth CF, Kiron MA, Weng W, Wester RT, Tracey WR, Knight DR, Buchholz RA, Kennedy SP.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):122-8. PubMed ID: 8996189
    [Abstract] [Full Text] [Related]

  • 16. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B, Arslan G, Nilsson C, Owman C, Lorenzen A, Schwabe U, Fredholm BB.
    Biochem Pharmacol; 1999 Jan 01; 57(1):65-75. PubMed ID: 9920286
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential development of adenosine A1 and A2b receptors in the rat duodenum.
    Peachey JA, Hourani SM, Kitchen I.
    Br J Pharmacol; 1996 Nov 01; 119(5):949-58. PubMed ID: 8922745
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.